A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase II study will assess the effectiveness of the combination of oral
cyclophosphamide and sirolimus in sarcoma patients with relapsed or widespread disease who
cannot be cured by surgery, radiation or conventional chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center